Analysts Expect Nextgen Healthcare Inc (NXGN) to Announce $0.21 Earnings Per Share

Share on StockTwits

Brokerages predict that Nextgen Healthcare Inc (NASDAQ:NXGN) will post earnings of $0.21 per share for the current quarter, Zacks Investment Research reports. Ten analysts have issued estimates for Nextgen Healthcare’s earnings. Nextgen Healthcare posted earnings of $0.16 per share during the same quarter last year, which suggests a positive year over year growth rate of 31.3%. The firm is scheduled to announce its next quarterly earnings report after the market closes on Thursday, May 23rd.

According to Zacks, analysts expect that Nextgen Healthcare will report full-year earnings of $0.84 per share for the current financial year. For the next fiscal year, analysts anticipate that the business will report earnings of $0.90 per share. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that cover Nextgen Healthcare.

Several research firms recently weighed in on NXGN. Zacks Investment Research upgraded shares of Nextgen Healthcare from a “hold” rating to a “buy” rating and set a $21.00 target price on the stock in a report on Friday, April 26th. Svb Leerink upgraded shares of Nextgen Healthcare from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $19.00 to $22.00 in a report on Thursday, April 25th. Finally, Leerink Swann upgraded shares of Nextgen Healthcare from a “market perform” rating to an “outperform” rating in a report on Thursday, April 25th. One analyst has rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $19.50.

A number of institutional investors have recently added to or reduced their stakes in the stock. Zebra Capital Management LLC increased its stake in Nextgen Healthcare by 7.5% during the 1st quarter. Zebra Capital Management LLC now owns 14,956 shares of the company’s stock worth $252,000 after buying an additional 1,040 shares during the period. Morgan Stanley increased its stake in Nextgen Healthcare by 130.3% during the 1st quarter. Morgan Stanley now owns 283,582 shares of the company’s stock worth $4,773,000 after buying an additional 160,467 shares during the period. Man Group plc purchased a new stake in Nextgen Healthcare during the 1st quarter worth $190,000. SEI Investments Co increased its stake in Nextgen Healthcare by 1,294.6% during the 1st quarter. SEI Investments Co now owns 16,763 shares of the company’s stock worth $276,000 after buying an additional 15,561 shares during the period. Finally, Goldman Sachs Group Inc. increased its stake in Nextgen Healthcare by 36.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 215,645 shares of the company’s stock worth $3,630,000 after buying an additional 57,345 shares during the period. 70.11% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ:NXGN traded up $0.23 during midday trading on Wednesday, hitting $19.35. 212,223 shares of the company’s stock traded hands, compared to its average volume of 208,792. The company has a current ratio of 1.32, a quick ratio of 1.31 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $1.25 billion, a price-to-earnings ratio of 33.95, a PEG ratio of 3.21 and a beta of 1.18. Nextgen Healthcare has a twelve month low of $13.89 and a twelve month high of $23.73.

Nextgen Healthcare Company Profile

NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.

Read More: Is it Safe to Invest in Commodities?

Get a free copy of the Zacks research report on Nextgen Healthcare (NXGN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nextgen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Comparing ENDRA Life Sciences  and The Competition
Comparing ENDRA Life Sciences and The Competition
Head-To-Head Comparison: CHESAPEAKE FINL/SH  versus Washington Federal
Head-To-Head Comparison: CHESAPEAKE FINL/SH versus Washington Federal
China Jo-Jo Drugstores  vs. 111  Head-To-Head Contrast
China Jo-Jo Drugstores vs. 111 Head-To-Head Contrast
Critical Analysis: Workhorse Group  & PACCAR
Critical Analysis: Workhorse Group & PACCAR
Reviewing Axos Financial  and BBX Capital
Reviewing Axos Financial and BBX Capital
Transatlantic Capital  and Digipath  Critical Survey
Transatlantic Capital and Digipath Critical Survey


© 2006-2019 Ticker Report